Pfizer & BioNTech’s mRNA Vaccine Study Begins
See Clinical Studies for more information.
October 15, 2020
REGN-COV2 Antibody Therapy Used for Treatment Study Also Implemented in CoVPN Prevention Study
REGN-COV-2 is testing a combination of two antibodies called REGN10933 and REGN10987 to determine whether they can prevent SARS-CoV-2, the virus that causes COVID-19. Learn more about the study and the antibodies.
October 8, 2020
Interested in volunteering for a COVID-19 Prevention Clinical Study?
Selecting the button below will take you to the CoVPN Volunteer Screening Registry.Volunteer Now!